The loss-making developer of cancer immunotherapies raised just enough financing last year to cross the valuation threshold for a Hong Kong listing.

Sunho Biologics gets green light for downsized IPO

The loss-making developer of cancer immunotherapies raised just enough financing last year to cross the valuation threshold for a Hong Kong listing Key Takeaways: Sunho Biologics has no revenue or…
Mao Geping eyes listing in Hong Kong, but family-business may not be the cup tea of the market

Mao Geping dolls up for Hong Kong IPO

The high-end cosmetics brand banks heavily on the name of its famous founder, which may be one of its biggest risks Key Takeaways: Mao Geping Cosmetics has filed for a…
Ximalaya files for IPO

Ximalaya aims high in third listing attempt

China’s leading podcast platform could become one of Hong Kong’s hottest tech offerings in recent years, boasting a huge base of loyal users and a recent move to profitability Key…